Methods and systems for modifying bioactive agent use

• US 9,282,927 B2
• Filed: 08/22/2008
• Issued: 03/15/2016
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Harvest Bio LLC
• Original Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Inventors: Hyde, Roderick A., Ishikawa, Muriel Y., Leuthardt, Eric C., Levien, Royce A., Lord, Robert W., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Lowell L. Jr., Wood, Victoria Y. H.
• Primary Examiner(s): NGUYEN, HIEP VAN
• Application Number:
  US12/229,531
• Publication Number:
  US 20090270693A1
• Time in Patent Office: 2,762 Days
• Field of Search: 705/2
• US Class Current: 1/1
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/05 Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves impedance plethysmography A61B5/0295; measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24
• CPC Class Codes: A61B 5/08 Detecting, measuring or recording devices for evaluating the respiratory organs A61B5/0205 takes precedence
• CPC Class Codes: A61B 5/16 Devices for psychotechnics using teaching or educational appliances G09B1/00 - G09B7/00; Testing reaction times ; Devices for evaluating the psychological state
• CPC Class Codes: A61B 5/24 Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes
• CPC Class Codes: A61B 5/4266 sweat secretion
• CPC Class Codes: A61B 5/48 Other medical applications
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61M 2205/50 with microprocessors or computers
• CPC Class Codes: A61M 2205/502 User interfaces, e.g. screens or keyboards
• CPC Class Codes: A61M 2205/52 with memories providing a history of measured variating parameters of apparatus or patient
• CPC Class Codes: A61M 2205/581 by audible feedback
• CPC Class Codes: A61M 2230/04 Heartbeat characteristics, e.g. ECG, blood pressure modulation
• CPC Class Codes: A61M 2230/10 Electroencephalographic signals
• CPC Class Codes: A61M 2230/30 Blood pressure A61M2230/04 takes precedence
• CPC Class Codes: A61M 2230/65 Impedance, e.g. conductivity, capacity
• CPC Class Codes: A61M 5/1723 : using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G06F 16/24575 : using context
• CPC Class Codes: G06F 3/011 : Arrangements for interaction with the human body, e.g. for user immersion in virtual reality blind teaching G09B21/00
• CPC Class Codes: G16H 20/10 : relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/20 : for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

Abstract

Methods, computer program products, and systems are described that include measuring at least one effect of a combined bioactive agent and artificial sensory experience on an individual and/or modifying at least one of the bioactive agent or the artificial sensory experience at least partially based on the at least one effect.

Claims

1. A combination treatment system comprising:

at least one in vivo type administration unit that includes at least

at least one housing;

at least one reservoir within the at least one housing and that is operable to contain at least one antidepressant agent;

at least one controllable valve or pump mechanism operable to transfer the at least one antidepressant agent from the at least one reservoir for delivery to at least one bodily site;

at least one wireless receiver operable to receive one or more wirelessly transmitted instructions; and

at least one controller communicably linked with the at least one wireless receiver and that at least one controllable valve or pump mechanism, which at least one controller is operable to control the at least one controllable valve or pump mechanism to deliver one or more dosages of the at least one antidepressant agent in accordance with one or more wirelessly transmitted instructions received by the at least one wireless receiver; and

at least one smartphone device communicably linked with the at least one administration unit, the at least one smartphone device including at least;

at least one sensor for monitoring visual appearance of an individual;

at least one wireless transmitter operable to communicate wirelessly with the at least one administration unit;

at least one display;

one or more media including one or more executable instructions; and

at least one processor operatively connected to the one or more media, wherein the at least one processor is configured to execute the one or more executable instructions to perform operations including at least;

monitoring appearance of the individual using the at least one sensor;

detecting at least one depression symptom of the individual based at least partly on monitored appearance of the individual which deviates from one or more specified levels of normalcy for the individual;

transmitting one or more instructions wirelessly to the at least one administration unit that control the at least one controllable valve or pump mechanism to deliver one or more dosages of the at least one antidepressant agent to at least one bodily site at least partly in response to detection of the at least one depression symptom of the individual based at least partly on monitored appearance of the individual which deviates from one or more specified levels of normalcy for the individual; and

implementing one or more modifications to at least one interpersonal interaction application at one or more staggered times relative to administration of the at least one antidepressant agent based at least partly on one or more pharmacokinetic profiles of the at least one antidepressant agent, the one or more staggered times corresponding to when the antidepressant agent is expected to be least effective.

2. A treatment system comprising:

a smartphone device communicably linked with an administration unit that includes at least a controllable delivery mechanism operable to control delivery of a medication, a wireless communication unit operable to receive one or more instructions, and a controller communicably linked with the wireless communication unit for controlling the delivery mechanism at least partly in response to one or more wirelessly received instructions,

wherein the smartphone device includes at least;

an input device for receiving one or more inputs of an individual;

a wireless communication unit operable to communicate wirelessly with the administration unit;

a storage medium including one or more executable instructions; and

a processor operatively connected to the storage medium, wherein the processor is configured to execute the one or more executable instructions to perform operations including at least;

receiving one or more inputs of an individual using the input device, which one or more inputs indicate a symptom;

transmitting one or more instructions wirelessly to the administration unit to control delivery of one or more dosages of the medication; and

implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication.

3. The system of claim 2, wherein implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication comprises:

implementing one or more sound aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication.

4. The system of claim 2, wherein the implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication comprises:

implementing one or more visual aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication.

5. The system of claim 2, wherein the implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication comprises:

implementing one or more aspects of an application on the smartphone device at a time when the medication is expected to be least effective.

6. The system of claim 2, wherein the processor is configured to execute the one or more executable instructions to further perform an operation including at least:

providing at least one artificial sensory experience at a specified time relative to administration of the medication.

7. The system of claim 2, wherein the processor is configured to execute the one or more executable instructions to further perform an operation including at least:

determining one or more modifications to dosage of the medication.

8. The system of claim 2, wherein the processor is configured to execute the one or more executable instructions to further perform an operation including at least:

selecting at least one artificial sensory experience based at least partly on monitored computer usage history of the individual.

9. The system of claim 2, wherein the implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication comprises:

implementing one or more aspects of an application on the smartphone device at a time that corresponds with peak effect of the medication.

10. The system of claim 2, wherein the implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication comprises:

altering access to at least one photo of specified subject matter of an application on the smartphone device at a staggered time relative to administration of the medication based at least partly on a specified effect of the medication.

11. The system of claim 2, further comprising:

one or more eyeglasses wearable by the individual that are operable to monitor one or more visible aspects of the individual.

12. The system of claim 2, further comprising:

at least one nasal administration unit configured to release one or more medications for nasal administration to the individual.

13. The system of claim 2, further comprising:

at least one vibration unit configured to implement vibration based at least partly on at least one measured aspect of the individual.

14. The system of claim 2, further comprising:

at least one transdermal administration unit operable to release at least one medication.

15. The system of claim 2, further comprising:

at least one administration unit operable to release at least one orally consumable medication.

16. A combination treatment system comprising:

an administration unit that includes at least;

a reservoir that is operable to contain a pain medication;

a controllable delivery mechanism operable to control delivery of the pain medication;

a wireless receiver operable to receive one or more instructions; and

a controller communicably linked with the wireless receiver, which controller is operable to control the delivery mechanism in accordance with one or more instructions received by the wireless receiver; and

a smartphone device communicably linked with the administration unit, the smartphone device including at least;

an input device for receiving one or more inputs of an individual;

a wireless transmitter operable to communicate wirelessly with the administration unit;

a storage medium including one or more executable instructions; and

a processor operatively connected to the storage medium, wherein the processor is configured to execute the one or more executable instructions to perform operations including at least;

receiving one or more inputs of an individual using the input device, which one or more inputs indicate a pain symptom;

transmitting one or more instructions wirelessly to the administration unit to control delivery of one or more dosages of the pain medication; and

implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the pain medication based at least partly on a specified effect of the pain medication.

17. A combination treatment system comprising:

an administration unit that includes at least;

a reservoir that is operable to contain an antipsychotic medication;

a controllable delivery mechanism operable to control delivery of the antipsychotic medication;

a wireless receiver operable to receive one or more instructions; and

a controller communicably linked with the wireless receiver, which controller is operable to control the delivery mechanism in accordance with one or more instructions received by the wireless receiver; and

a smartphone device communicably linked with the administration unit, the smartphone device including at least;

an input device for receiving one or more inputs of an individual;

a wireless transmitter operable to communicate wirelessly with the administration unit;

a storage medium including one or more executable instructions; and

a processor operatively connected to the storage medium, wherein the processor is configured to execute the one or more executable instructions to perform operations including at least;

receiving one or more inputs of an individual using the input device, which one or more inputs indicate a mental symptom;

transmitting one or more instructions wirelessly to the administration unit to control delivery of one or more dosages of the antipsychotic medication; and

implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the antipsychotic medication based at least partly on a specified effect of the antipsychotic medication.

18. A combination treatment system comprising:

a transdermal administration unit that includes at least;

a reservoir that is operable to contain a medication for treating addiction;

a controllable delivery mechanism operable to control delivery of the medication for treating addiction;

a wireless communication unit; and

a controller communicably linked with the wireless communication unit, which controller is operable to control the delivery mechanism in accordance with one or more instructions received by the wireless communication unit; and

a smartphone device communicably linked with the administration unit, the smartphone device including at least;

an input device for receiving one or more inputs of an individual;

a wireless communication unit operable to communicate wirelessly with the administration unit;

a storage medium including one or more executable instructions; and

a processor operatively connected to the storage medium, wherein the processor is configured to execute the one or more executable instructions to perform operations including at least;

receiving one or more inputs of an individual using the input device, which one or more inputs indicate a specified mental symptom;

transmitting one or more instructions wirelessly to the administration unit to control delivery of one or more dosages of the medication for treating addiction; and

implementing one or more aspects of an application on the smartphone device at a staggered time relative to administration of the medication for treating addiction based at least partly on a specified effect of the medication for treating addiction.